Patent: 10,238,700

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,238,700

Title:	Oncolytic virus adjunct therapy with agents that increase virus infectivity
Abstract:	Provided are adjunct therapies for use in combinations and compositions with an oncolytic virus, such as a vaccinia virus. The adjunct therapies include co-administration and co-formulation of a complement inhibitor and/or a lipid emulsion composition with the oncolytic virus. Also provided herein are therapeutic methods using the adjunct therapies for treatment of disease and conditions employing an oncolytic therapeutic virus, such as for the treatment of hyperproliferative diseases or conditions including tumors or cancers.
Inventor(s):	Szalay; Aladar A. (Highland, CA), Cappello; Joseph (San Diego, CA), Chen; Nanhai G. (San Diego, CA), Minev; Boris (San Diego, CA)
Assignee:	Genelux Corporation (San Diego, CA)
Application Number:	15/109,214
Patent Claims:	see list of patent claims

Details for Patent 10,238,700

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Alexion Pharm	SOLIRIS	eculizumab	INJECTABLE; IV (INFUSION)	125166	001	2007-03-16	Start Trial	Genelux Corporation (San Diego, CA)	2034-01-02	RX	Orphan	search
Emergent Product Development Gaithersburg Inc.	ACAM2000	smallpox (vaccinia) vaccine, live	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	125158	1	2007-08-31	Start Trial	Genelux Corporation (San Diego, CA)	2034-01-02			search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,238,700

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015103438	Start Trial
United States of America	2016339066	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.